Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Fiona Yull"'
Autor:
Mohammed N. Tantawy, J. Oliver McIntyre, Fiona Yull, M. Wade Calcutt, Dmitry S. Koktysh, Andrew J. Wilson, Zhongliang Zu, Jeff Nyman, Julie Rhoades, Todd E. Peterson, Daniel Colvin, Lisa J. McCawley, Jerri. M. Rook, Barbara Fingleton, Marta Ann Crispens, Ronald D. Alvarez, John C. Gore
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Background It has been shown that tumor microenvironment (TME) hydroxyapatite (HAP) is typically associated with many malignancies and plays a role in tumor progression and growth. Additionally, acidosis in the TME has been reported to play
Externí odkaz:
https://doaj.org/article/9b560d0bef2f4ba0a581210d8528af70
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 24, Iss 2, Pp 63-75 (2022)
Histone deacetylase inhibitors (HDACi) sensitize homologous recombination (HR)-proficient human ovarian cancer cells to PARP inhibitors (PARPi). To investigate mechanisms of anti-tumor effects of combined HDACi/PARPi treatment we performed transcript
Externí odkaz:
https://doaj.org/article/8bc38eee187b4be7af6ce79aa0344d9a
Publikováno v:
Cancers, Vol 10, Iss 10, p 366 (2018)
Ovarian cancer, a rare but fatal disease, has been a challenging area in the field of gynecological cancer. Ovarian cancer is characterized by peritoneal metastasis, which is facilitated by a cross-talk between tumor cells and other cells in the tumo
Externí odkaz:
https://doaj.org/article/ff40c59e60a1431a8306c85913afaf0d
Autor:
Josiane E. Eid, Fiona Yull, Ethan Lee, Timothy S. Blackwell, Mario R. Capecchi, Darren Orton, Linda Gleaves, Barbara Fingleton, Michael N. VanSaun, Kenyi Saito-Diaz, Christina B. Garcia, Taylor P. Sherrill, Andrea L. Frump, Whitney Barham
Supplementary Figure S9 - PDF file 867K,Figure S9: The SYT-SSX2 domain SSXRD executes �-catenin activation and myogenic differentiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6201b00228119ab3b4bdb409250f733
https://doi.org/10.1158/2159-8290.22529105.v1
https://doi.org/10.1158/2159-8290.22529105.v1
Autor:
Josiane E. Eid, Fiona Yull, Ethan Lee, Timothy S. Blackwell, Mario R. Capecchi, Darren Orton, Linda Gleaves, Barbara Fingleton, Michael N. VanSaun, Kenyi Saito-Diaz, Christina B. Garcia, Taylor P. Sherrill, Andrea L. Frump, Whitney Barham
Supplementary Figures S4, S5, S6, S7 - PDF file 1832K, Figure S4:Pyrvinium effect on beta-catenin in SYT-SSX2 expressing C2C12 and synovial sarcoma cells Figure S5:Phosphorylated �-catenin and full-length APC in HS-SY-II and SYO-1 SS cells Figure S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2115522f5cd7f172230fc8ffe676028f
https://doi.org/10.1158/2159-8290.22529099
https://doi.org/10.1158/2159-8290.22529099
Autor:
Josiane E. Eid, Fiona Yull, Ethan Lee, Timothy S. Blackwell, Mario R. Capecchi, Darren Orton, Linda Gleaves, Barbara Fingleton, Michael N. VanSaun, Kenyi Saito-Diaz, Christina B. Garcia, Taylor P. Sherrill, Andrea L. Frump, Whitney Barham
Supplementary Figure S11 and Tables S1-S3 - PDF file 460K, Figure S11: Regulation of an embryonic Wnt-interactive network by SYT-SSX2 and in human synovial sarcomas Table S1: Differentially regulated Wnt components in mesenchymal precursor cells expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5b26a01dd28d986070054c2c0a149d
https://doi.org/10.1158/2159-8290.22529111.v1
https://doi.org/10.1158/2159-8290.22529111.v1
Autor:
Josiane E. Eid, Fiona Yull, Ethan Lee, Timothy S. Blackwell, Mario R. Capecchi, Darren Orton, Linda Gleaves, Barbara Fingleton, Michael N. VanSaun, Kenyi Saito-Diaz, Christina B. Garcia, Taylor P. Sherrill, Andrea L. Frump, Whitney Barham
Supplementary Figures S2 and S3 - PDF file 2332K, Figure S2:SG3 tumors are positive for beta-catenin and Myf5 Figure S3:Normal development of Myf5 myoblasts in beta-catenin knockout mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c394a5927b811f68ab19e201dea513d
https://doi.org/10.1158/2159-8290.22529102
https://doi.org/10.1158/2159-8290.22529102
Autor:
Josiane E. Eid, Fiona Yull, Ethan Lee, Timothy S. Blackwell, Mario R. Capecchi, Darren Orton, Linda Gleaves, Barbara Fingleton, Michael N. VanSaun, Kenyi Saito-Diaz, Christina B. Garcia, Taylor P. Sherrill, Andrea L. Frump, Whitney Barham
Supplementary Methods and Legends - PDF file 130K, Methods:Additional information on experimental techniques Legends: describing supplementary figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf3fb1105b02d153ebf86fabd70e9aa8
https://doi.org/10.1158/2159-8290.22529096
https://doi.org/10.1158/2159-8290.22529096
Publikováno v:
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 24, Iss 2, Pp 63-75 (2022)
Neoplasia: An International Journal for Oncology Research, Vol 24, Iss 2, Pp 63-75 (2022)
Highlights • Panobinostat in combination with olaparib reduces homologous recombination (HR) proficient tumor cell viability. • This combination favors anti-tumorigenic macrophages and enhances CD8+ T cell infiltration into tumors. • As a resul
Publikováno v:
Cancer Research. 83:4973-4973
Background: Ovarian cancer is the most lethal gynecologic malignancy, with a 5-year survival rate of less than 50%. To have a major impact on improving clinical outcomes, a better understanding of the progression of disease and identification of trul